DDD Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.7M Buy
835,246
+220,155
+36% +$5.32M 1.07% 37
2026
Q2
$15.1M Sell
615,091
-2,993
-0.5% -$69.2K 0.94% 44
2026
Q1
$14.8M Sell
618,084
-308,934
-33% -$7.55M 1.02% 36
2025
Q4
$21M Sell
927,018
-826,351
-47% -$18M 1.34% 19
2025
Q3
$35.3M Buy
1,753,369
+108,941
+7% +$1.83M 2.24% 5
2025
Q2
$23.5M Buy
1,644,428
+151,436
+10% +$1.77M 2.52% 10
2025
Q1
$15.7M Buy
1,492,992
+999,716
+203% +$11.3M 1.9% 25
2024
Q4
$5.97M Buy
+493,276
New +$6.45M 0.73% 37

Other funds holding ELAN

DDD Partners's ELAN Position: Q3 2026 in Review

DDD Partners increased its Elanco Animal Health (ELAN) stake by 36% in Q3 2026, buying an estimated $5.32M and bringing the position to 835,246 shares worth $18.7M. The position accounts for 1.07% of the portfolio, ranked #37.

DDD Partners first reported a position in ELAN in Q4 2024 and has held it in 8 quarters since. The position peaked at $35.3M in Q3 2025. 185 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • DDD Partners held 835,246 shares of Elanco Animal Health worth $18.7M as of Q3 2026.
  • DDD Partners bought 220,155 Elanco Animal Health shares in Q3 2026, an estimated $5.32M.
  • Elanco Animal Health made up 1.07% of DDD Partners's portfolio in Q3 2026, its #37 holding.
  • DDD Partners first reported a position in Elanco Animal Health in Q4 2024 and has held it in 8 quarters since.
  • DDD Partners's Elanco Animal Health position peaked at $35.3M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on DDD Partners's 13F filing for Q3 2026, filed 2 Nov 2026.